Evaluation of the stability of vancomycin solutions at concentrations used in clinical services
Solutions at 5 and 10 mg/mL were stable for 58 days at +4°C in 100 mL polyvinyl chloride (PVC) infusion bags with no specification with regard to protection from light.8 Vancomycin was stable at 5 mg/mL in PVC bags for 48 hours at +22°C without protection from light and for 7 days at +4°C with prote...
Saved in:
Published in: | European journal of hospital pharmacy. Science and practice Vol. 27; no. e1; pp. e87 - e92 |
---|---|
Main Authors: | , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
England
BMJ Publishing Group LTD
01-03-2020
BMJ Group BMJ Publishing Group |
Series: | European Journal of Hospital Pharmacy |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Solutions at 5 and 10 mg/mL were stable for 58 days at +4°C in 100 mL polyvinyl chloride (PVC) infusion bags with no specification with regard to protection from light.8 Vancomycin was stable at 5 mg/mL in PVC bags for 48 hours at +22°C without protection from light and for 7 days at +4°C with protection from light.9 Raverdy et al 10 examined the stability of vancomycin diluted in 5% dextrose at high concentration (83 mg/mL) and was stable for 72 hours at +37°C. However, none of these studies reflects real infusion conditions as vancomycin is usually administered at 30 mg/kg/day.11 12 In practice, clinical services infuse vancomycin into electric syringe pumps using 50 mL (for adults) or 20 mL (for children) syringes. The aim of this work was therefore to study vancomycin stability in syringes and assess its use (pH, osmolality, number of particles) during a continuous 24-hour infusion with and without inline filters at four concentrations—25, 40, 60 and 80 mg/mL—reconstituted in two solvents (WFI and saline solution) and diluted in saline solution. To perform the mobile phase, acetonitrile (high-performance liquid chromatography (HPLC) gradient grade; VWR Chemicals, Fontenay-sous-Bois, France), phosphate buffer (potassium dihydrogen phosphate; Merck, Calais, France), ultrapure water (Purelab Classic Elga System, Veolia, Wasquehal, France) and orthophosphoric acid (Merck) were used. The number of particles ≥10 µm and ≥25 µm should not exceed 6000 and 600 particles per syringe, respectively.18 Statistical analysis The Mann-Whitney U test compared the following filtered and unfiltered measurements: cumulative amount with both reconstitution solvents at T24, and the number of particles, pH and osmolality at T0 and T24. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 EAHP Statement 3: Production and Compounding. |
ISSN: | 2047-9956 2047-9964 |
DOI: | 10.1136/ejhpharm-2019-002076 |